Koizumi S, Kyoya S, Miyawaki T M, Kidani H, Funabashi T
Clin Chim Acta. 1977 Jun 15;77(3):301-6. doi: 10.1016/0009-8981(77)90233-9.
An autopsied case with congenital lipoid adrenal hyperplasia (Prader disease) was presented. The cholesterol side-chain cleavage (SCC) enzyme activity in adrenal mitochondria of this case was assayed with [3H]cholesterol as substrate, combined with purified bovine adrenodoxin and adrenodoxin reductase, by measuring the amount of [3H]pregnenolone formed. The cytochrome P-450 content was also measured by recording the difference absorption spectra of carbon monoxide-complexed P-450. The cholesterol SCC enzyme activity in adrenal mitochondria of Prader disease was 0.81 nmol pregnenolone/nmol P-450 per min, which was approximately 10% of that in normal tissue. The content of cytochrome P-450 was 0.074 nmol/mg protein, which was about half of that in controls. These results indicate that there is a cholesterol SCC enzyme deficiency in adrenal mitochondria in this disease.
本文报告了一例先天性类脂性肾上腺增生(普拉德病)的尸检病例。以[3H]胆固醇为底物,结合纯化的牛肾上腺皮质铁氧化还原蛋白和肾上腺皮质铁氧化还原蛋白还原酶,通过测量生成的[3H]孕烯醇酮的量,测定了该病例肾上腺线粒体中胆固醇侧链裂解(SCC)酶的活性。还通过记录一氧化碳复合P-450的差异吸收光谱来测量细胞色素P-450的含量。普拉德病患者肾上腺线粒体中胆固醇SCC酶的活性为0.81 nmol孕烯醇酮/(nmol P-450·min),约为正常组织的10%。细胞色素P-450的含量为0.074 nmol/mg蛋白质,约为对照组的一半。这些结果表明,该疾病的肾上腺线粒体中存在胆固醇SCC酶缺乏。